398 related articles for article (PubMed ID: 1332033)
21. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
Sonsalla PK; Manzino L; Heikkila RE
J Pharmacol Exp Ther; 1988 Oct; 247(1):180-5. PubMed ID: 2971797
[TBL] [Abstract][Full Text] [Related]
22. 6-Hydroxydopamine lesions of rat substantia nigra up-regulate dopamine-induced phosphorylation of the cAMP-response element-binding protein in striatal neurons.
Cole DG; Kobierski LA; Konradi C; Hyman SE
Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9631-5. PubMed ID: 7937819
[TBL] [Abstract][Full Text] [Related]
23. Control of the subthalamic innervation of substantia nigra pars reticulata by D1 and D2 dopamine receptors.
Ibañez-Sandoval O; Hernández A; Florán B; Galarraga E; Tapia D; Valdiosera R; Erlij D; Aceves J; Bargas J
J Neurophysiol; 2006 Mar; 95(3):1800-11. PubMed ID: 16306171
[TBL] [Abstract][Full Text] [Related]
24. Dopamine acts on D2 receptors to increase potassium conductance in neurones of the rat substantia nigra zona compacta.
Lacey MG; Mercuri NB; North RA
J Physiol; 1987 Nov; 392():397-416. PubMed ID: 2451725
[TBL] [Abstract][Full Text] [Related]
25. Comparison of effects of D-1 and D-2 dopamine receptor agonists on neurons in the rat caudate putamen: an electrophysiological study.
Hu XT; Wang RY
J Neurosci; 1988 Nov; 8(11):4340-8. PubMed ID: 2972814
[TBL] [Abstract][Full Text] [Related]
26. Dopaminergic modulation of early signs of excitotoxicity in visualized rat neostriatal neurons.
Cepeda C; Colwell CS; Itri JN; Gruen E; Levine MS
Eur J Neurosci; 1998 Nov; 10(11):3491-7. PubMed ID: 9824462
[TBL] [Abstract][Full Text] [Related]
27. Nigrostriatal lesion and dopamine agonists affect firing patterns of rodent entopeduncular nucleus neurons.
Ruskin DN; Bergstrom DA; Walters JR
J Neurophysiol; 2002 Jul; 88(1):487-96. PubMed ID: 12091570
[TBL] [Abstract][Full Text] [Related]
28. Antisense oligodeoxynucleotide inhibits D2 dopamine receptor-mediated behavior and D2 messenger RNA.
Weiss B; Zhou LW; Zhang SP; Qin ZH
Neuroscience; 1993 Aug; 55(3):607-12. PubMed ID: 8413923
[TBL] [Abstract][Full Text] [Related]
29. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
LaHoste GJ; Marshall JF
Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
[TBL] [Abstract][Full Text] [Related]
30. Dopamine enhances glutamate-induced excitation of rat striatal neurons by cooperative activation of D1 and D2 class receptors.
Hu XT; White FJ
Neurosci Lett; 1997 Mar; 224(1):61-5. PubMed ID: 9132692
[TBL] [Abstract][Full Text] [Related]
31. Physiological release of striatal acetylcholine in vivo: modulation by D1 and D2 dopamine receptor subtypes.
DeBoer P; Abercrombie ED
J Pharmacol Exp Ther; 1996 May; 277(2):775-83. PubMed ID: 8627558
[TBL] [Abstract][Full Text] [Related]
32. N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra.
Huang KX; Bergstrom DA; Ruskin DN; Walters JR
Synapse; 1998 Sep; 30(1):18-29. PubMed ID: 9704877
[TBL] [Abstract][Full Text] [Related]
33. Dyskinetic potential of dopamine agonists is associated with different striatonigral/striatopallidal zif-268 expression.
Carta AR; Frau L; Pinna A; Morelli M
Exp Neurol; 2010 Aug; 224(2):395-402. PubMed ID: 20452347
[TBL] [Abstract][Full Text] [Related]
34. Dopamine receptor regulation of Ca2+ levels in individual isolated nerve terminals from rat striatum: comparison of presynaptic D1-like and D2-like receptors.
Wu J; Dougherty JJ; Nichols RA
J Neurochem; 2006 Jul; 98(2):481-94. PubMed ID: 16805841
[TBL] [Abstract][Full Text] [Related]
35. In vivo administration of an oligodeoxynucleotide antisense to the D2 dopamine receptor messenger RNA inhibits D2 dopamine receptor-mediated behavior and the expression of D2 dopamine receptors in mouse striatum.
Zhou LW; Zhang SP; Qin ZH; Weiss B
J Pharmacol Exp Ther; 1994 Feb; 268(2):1015-23. PubMed ID: 8113958
[TBL] [Abstract][Full Text] [Related]
36. Polydipsia and dopamine: behavioral effects of dopamine D1 and D2 receptor agonists and antagonists.
Mittleman G; Rosner AL; Schaub CL
J Pharmacol Exp Ther; 1994 Nov; 271(2):638-50. PubMed ID: 7965779
[TBL] [Abstract][Full Text] [Related]
37. Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated.
Cepeda C; Buchwald NA; Levine MS
Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9576-80. PubMed ID: 7692449
[TBL] [Abstract][Full Text] [Related]
38. Selective modifications in GAD67 mRNA levels in striatonigral and striatopallidal pathways correlate to dopamine agonist priming in 6-hydroxydopamine-lesioned rats.
Carta AR; Fenu S; Pala P; Tronci E; Morelli M
Eur J Neurosci; 2003 Nov; 18(9):2563-72. PubMed ID: 14622157
[TBL] [Abstract][Full Text] [Related]
39. Stimulation of both D1 and D2 dopamine receptors appears necessary for full expression of postsynaptic effects of dopamine agonists: a neurophysiological study.
Carlson JH; Bergstrom DA; Walters JR
Brain Res; 1987 Jan; 400(2):205-18. PubMed ID: 2880637
[TBL] [Abstract][Full Text] [Related]
40. Electrophysiological verification of the presence of D1 and D2 dopamine receptors within the ventral pallidum.
Napier TC; Maslowski-Cobuzzi RJ
Synapse; 1994 Jul; 17(3):160-6. PubMed ID: 7974198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
